$AVIR SEC Filings

Filed On	Filing
06 Oct 2026	SCHEDULE 13G
12 Aug 2026	10-Q
12 Aug 2026	8-K: Results of Operations and Financial Condition
23 Jun 2026	Form 4: Lucidi Bruno, Director Received 29,600 shares by exercise or conversion · Granted 26,700 Restricted Stock Units · Granted 37,700 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Berger Franklin M, Director Received 29,600 shares by exercise or conversion · Granted 26,700 Restricted Stock Units · Granted 37,700 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Berman Howard, Director Granted 26,700 Restricted Stock Units · Granted 37,700 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Duncan Barbara Gayle, Director Received 29,600 shares by exercise or conversion · Granted 26,700 Restricted Stock Units · Granted 37,700 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Polsky Bruce, Director Received 29,600 shares by exercise or conversion · Granted 26,700 Restricted Stock Units · Granted 37,700 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Murphy Polly A., Director Received 29,600 shares by exercise or conversion · Granted 26,700 Restricted Stock Units · Granted 37,700 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Adams Jerome M., Director Received 29,600 shares by exercise or conversion · Granted 26,700 Restricted Stock Units · Granted 37,700 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Kirsch Arthur S, Director Granted 26,700 Restricted Stock Units · Granted 37,700 Stock Option (Right to Buy)
22 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
21 May 2026	Form 4/A: Murphy Polly A., Director Bought 6,100 shares ($25.4K)
20 May 2026	Form 4: Murphy Polly A., Director Bought 6,100 shares ($25.4K)
12 May 2026	10-Q
12 May 2026	8-K: Results of Operations and Financial Condition
06 May 2026	SCHEDULE 13G/A
27 Apr 2026	DEFA14A
27 Apr 2026	Proxy statement: annual meeting on June 18, 2026 CEO pay $3.4M, down 19% · say-on-pay vote
26 Mar 2026	SCHEDULE 13G/A

Comments